Mumbai Metro-3 Likely To Be Completed By December 2021
The Mumbai Metro Rail Corporation is likely to complete the Metro-3 corridor (Colaba-Bandra-SEEPZ) by December 2021 instead of early 2020.
The 33.5-kilometre underground metro is to be commissioned in two phases. Work on the first phase of the project will be completed by May 2021 while the remaining corridor will be completed by end of the year, Ashwini Bhide, managing director of MMRC said.
Metro-3 is a part of the 172-km metro network in Mumbai and its suburbs. The cost of the third line of metro alone is Rs 23,136 crore.
The project has faced numerous hurdles following opposition and petitions from environmental groups and citizens, including the Bombay High Court's order against the cutting of trees along the construction site earlier this year. More recently, the high court stayed for two weeks the tunnelling work near the heritage JN Petit Institute building in south Mumbai for the proposed Metro-3 line.
Bhide said the project will see cost overruns due to these unexpected delays. “The cost doesn't include delays that occurred in the initial days. So obviously there will be cost overruns but we will assess all of that once the system tenders re finalised,” she added.
MMRC claims that once the Metro-3 commences, it will reduce vehicular traffic by 35 percent, saving about 2.5 lakh litres of petrol every day. “The green benefits of the project are such that they would outweigh any temporary damage,” said Bhide.
The Mumbai Metro Line 3 has the capacity to carry about 17 lakh passengers per day as it traverses through areas that house major employment centres of the city, she added.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.